Boston Pharmaceuticals, a clinical-stage biopharmaceutical company developing efimosfermin alfa, an investigational, once-monthly FGF21 analogue for the treatment of metabolic dysfunction-associated ...

The pontiff, who died Monday at the age of 88, periodically disappointed some of his most progressive church supporters. One critic said that Francis “was at heart a conservative” who had a ...

An ambitious citywide exhibition will feature 20 public art commissions at outdoor venues and partnering museums.

Former State Department official Edward Fishman warns that Trump's strategy of global economic chaos will backfire ...

Legendary economist Art Laffer admitted on Wednesday he’s terrified ... Despite the criticism, the Reagan-era economist has been a fan of Trump over the years. He referred to him as "a great ...

In its legal fight to keep an artwork, the Art Institute of Chicago just suffered ... stolen property in “one of the most flagrant Nazi-era lootings of a Holocaust victim’s cultural property ...

Why rush to sell in a cooling market when you can borrow against your art and wait for prices to rebound? Welcome to the new age of art finance. Fatih Aktas/Anadolu via Getty Images As we enter ...

The Allentown Art Museum’s newly acquired Tiffany windows, on display at its Kress Gallery to the public for the first time this weekend, are grandiose to look at from afar. The 14-foot-tall ...

Frustrated with their party's response to President Trump, a wave of young Democrats are challenging incumbents in safe blue ...

Saffronart at 25: ‘It’s an exciting time’: Dinesh Vazirani on the new era of Indian art collecting Despite a 25% dip in the global art market—the lowest since 2020, according to the Art ...